Home » Reports » Broker Ratings » Omega Diagnostics Group Plc 51.4% Potential Upside Indicated by finnCap
broker ratings

Omega Diagnostics Group Plc 51.4% Potential Upside Indicated by finnCap

Omega Diagnostics Group Plc using EPIC/TICKER code LON:ODX has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘CORPORATE’ this morning by analysts at finnCap. Omega Diagnostics Group Plc are listed in the Health Care sector within AIM. finnCap have set a target price of 28 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 51.4% from today’s opening price of 18.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 0 points and increased 1.7 points respectively.
The 52 week high share price is 21 GBX while the year low share price is currently 13.5. There are currently 109,950,582 shares in issue with the average daily volume traded being 57,575. Market capitalisation for LON:ODX is £20,307,872 GBP.


Omega Diagnostics Group Plc is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!